Physician profile
David W Riggio
NPI 1467455063
$49,647.79
in general payments reported to CMS, 2019-2025
28 companies · $10K in 2025
The $10K reported for 2025 was more than what 81% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,932 · 2020: $2,895 · 2021: $3,538 · 2022: $5,970 · 2023: $17K · 2024: $5,773 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Consulting Fee: $9,500 · Travel and Lodging: $9,172 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,571.73 |
| Consulting Fee | $9,500.00 |
| Travel and Lodging | $9,171.64 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $16,136.75 | 2019-2025 | Igt Devices Undivided, (9520) Igt Devices Undivided, Lm Undivided |
| Abbott Laboratories | $10,878.18 | 2019-2025 | Aveir, Ensite Precision, Ensite |
| Medtronic, INC. | $6,777.53 | 2021-2025 | Diamondtemp Bidirectional Ablation Catheter, Pulseselect, Na |
| Boston Scientific Corporation | $4,066.35 | 2019-2025 | Watchman Flx, Emblem Mri S-Icd, Watchman Access System |
| Biosense Webster, INC. | $3,718.37 | 2022-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Atricure, INC. | $1,534.30 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $1,326.40 | 2020-2025 | Optimizer |
| Cvrx, INC. | $1,147.50 | 2021-2025 | Barostim Neo System |
| Cook Incorporated | $655.58 | 2019-2022 | |
| Medtronic Vascular, INC. | $503.89 | 2019-2020 | |
| Medical Device Business Services, INC. | $443.56 | 2023 | Carto 3 |
| Biotronik INC. | $417.04 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $282.87 | 2019-2025 | Lifevest |
| Cardiva Medical, INC. | $245.75 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Angiodynamics, INC. | $227.70 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ebr Systems, INC. | $158.57 | 2025 | |
| Shockwave Medical, INC | $154.93 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $146.20 | 2025 | Torus Stent Graft System, Endocross Device |
| Janssen Pharmaceuticals, INC | $141.27 | 2019-2022 | |
| Cook Medical LLC | $123.84 | 2019 | |
| Kestra Medical Technology Services, INC. | $105.36 | 2022-2025 | Assure Wcd |
| Pfizer INC. | $97.96 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $97.22 | 2020-2025 | |
| Bardy Diagnostics, INC. | $90.00 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $56.22 | 2019-2021 | |
| Abiomed | $51.19 | 2020-2021 | |
| Elutia, INC. | $44.74 | 2019-2022 | |
| Terumo Medical Corporation | $18.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Riggio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.